Market Tracker

10/24 6:05pm ET

Abbott Laboratories (NYSE:ABT)

42.46
Data as of Oct 24
 +0.03 / +0.07%
Today’s Change
35.65
Today|||52-Week Range
44.20
+10.77%
Year-to-Date

Today’s Trading

Previous close42.43
Today’s open42.34
Day’s range42.12 - 42.67
Volume4,676,934
Average volume (3 months)4,584,238
Market cap$63.8B
Dividend yield2.07%
Data as of 4:02pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-56.45%
Earnings growth (this year)+11.97%
Earnings growth (next 5 years)+10.10%
Revenue growth (last year)-45.21%
P/E ratio30.8
Price/Sales2.73
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
ACTActavis PLC+3.12+1.32%
AGNAllergan Inc+0.84+0.46%
LLYEli Lilly and Co+1.70+2.64%
CELGCelgene Corp+2.84+2.83%
Data as of 4:03pm ET, 10/24/2014

Financials

Last reporting dateOctober 22, 2014
EPS forecast (this quarter)$0.62
Annual revenue (last year)$21.8B
Annual profit (last year)$2.6B
Net profit margin10.91%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive Vice President
Thomas C. Freyman
Corporate headquarters
Abbott Park, Illinois

Forecasts